October 2, 2023Healio: An AI-powered device to identify low left ventricular ejection fraction in patients at risk for HF gained 510(k) clearance…
October 2, 2023Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients…
June 22, 2023Fierce Biotech: For the fourth time in half as many years, Anumana has earned the FDA’s breakthrough device designation for…
June 22, 2023Medical Device Network: The US Food and Drug Administration (FDA) has granted breakthrough device designation (BDD) for the electrocardiogram-artificial intelligence…
June 21, 2023Healio: Anumana announced it received FDA breakthrough device designation for its artificial intelligence-guided ECG algorithm for the early identification of…
June 21, 2023DAIC: Anumana, Inc., a leading AI-driven health technology company, has received Breakthrough Device Designation from the U.S. Food and Drug…
June 21, 2023Cardiovascular Business: Anumana, a Massachusetts-based healthcare technology company focused on artificial intelligence (AI), has received a breakthrough device designation from…- June 21, 2023Bioworld: Anumana Inc. has garnered a U.S. FDA breakthrough device designation for its artificial intelligence (AI)-powered electrocardiogram-based algorithm for early…
- June 21, 2023Developed in collaboration with Mayo Clinic, with support from Pfizer, this ECG-AI algorithm aims to aid physicians in earlier identification…
March 20, 2023Fierce Medtech: Since its humble beginnings back in 2012, the Fierce 15 has made a point of spotlighting the most…
Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors
